Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

August 2024

Core topics in this month’s edition include:

  • Neffy (epinephrine) – new drug approval
  • Enzeevu (aflibercept-abzv) and Pavblu (aflibercept-ayyh)– Biosimilars to Eylea
  • ACAM2000 (smallpox and mpox) – new indication for mpox

Download PDF

Rx navigation